Schellekens_BLongum_Obesity_Stress_EBIOM_103176 (003)


H. Schellekens et al. / EBioMedicine xxx (xxxx) 103176

[76] V.L. Wester, S.M. Staufenbiel, M.A. Veldhorst, J.A. Visser, L. Manenschijn, J.W. Koper, et al. Long-term cortisol levels measured in scalp hair of obese patients. Obesity 2014;22(9):1956 – 1958. [77] S.E. Jackson, C. Kirschbaum, A Steptoe Hair cortisol and adiposity in a population-based sample of 2,527 men and women aged 54 to 87 years. Obesity 2017;25(3):539 – 544. [78] J.M. Friedman, J.L. Halaas Leptin and the regulation of body weight in mammals. Nature 1998;395(6704):763 – 770. [79] H. Cui, M. Lopez, K Rahmouni The cellular and molecular bases of leptin and ghrelin resistance in obesity. Nat Rev Endocrinol 2017;13(6):338 – 351. [80] O. Ilnytska, G. Argyropoulos The role of the Agouti-Related Protein in energy balance regulation. Cell Mol Life Sci 2008;65(17):2721 – 2731. [81] W. Zhang, M.A. Cline, E.R Gilbert Hypothalamus-adipose tissue crosstalk: neuropeptide Y and the regulation of energy metabolism. Nutr Metab 2014;11. [82] D.R. Tian, X.D. Li, Y.S. Shi, Y. Wan, X.M. Wang, J.K. Chang, et al. Changes of hypothalamic alpha-MSH and CART peptide expression in diet-induced obese rats. Peptides 2004;25(12):2147 – 2153. [83] H.T. Bergen, T. Mizuno, J. Taylor, C.V Mobbs Resistance to diet-induced obesity is associated with increased proopiomelanocortin mRNA and decreased neuropeptide Y mRNA in the hypothalamus. Brain Res 1999;851(1 – 2):198 – 203. [84] K.E. Wortley, G.Q. Chang, Z. Davydova, S.K. Fried, S.F Leibowitz Cocaine- and amphetamine-regulated transcript in the arcuate nucleus stimulates lipid metabolism to control body fat accrual on a high-fat diet. Regul Pept 2004;117(2):89 – 99. [85] C.M. Chapman, G.R. Gibson, I Rowland Health benefits of probiotics: are mixtures more effective than single strains? Eur J Nutr 2011;50(1):1 – 17. [86] M. Jura, L.P Kozak Obesity and related consequences to ageing. Age (Dordr) 2016;38(1):23. [87] C. Emerging Risk Factors, N. Sarwar, P. Gao, S.R. Seshasai, R. Gobin, S. Kaptoge, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010;375(9733):2215 – 2222. [88] S. Chatterjee, K. Khunti, M.J Davies Type 2 diabetes. Lancet 2017;389(10085):2239 – 2251. [89] R.S. Ahima Ghrelin-a new player in glucose homeostasis? Cell Metab 2006;3(5):301 – 302. [90] Y. Wang, P.M. Nishina, J.K Naggert Degradation of IRS1 leads to impaired glucose uptake in adipose tissue of the type 2 diabetes mouse model TALLYHO/ Jng. J Endocrinol 2009;203(1):65 – 74. [91] X.C. Dong, S.M. Park, X.Y. Lin, K. Copps, X.J. Yi, M.F White Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth. J Clin Invest 2006;116(1):101 – 114. [92] H. Schellekens, T.G. Dinan, J.F Cryan Ghrelin at the interface of obesity and reward. Vitam Horm 2013;91:285 – 323. [93] T.L. Horvath, T. Castaneda, M. Tang-Christensen, U. Pagotto, M.H Tschop Ghrelin as a potential anti-obesity target. Curr Pharm Des 2003;9(17):1383 – 1395. [94] A.M. Wren, C.J. Small, C.R. Abbott, W.S. Dhillo, L.J. Seal, M.A. Cohen, et al. Ghrelin causes hyperphagia and obesity in rats. Diabetes 2001;50(11):2540 – 2547. [95] G. Collden, M.H. Tschop, T.D Muller Therapeutic potential of targeting the ghrelin pathway. Int J Mol Sci 2017;18(4). [96] H. Schellekens, B.C. Finger, T.G. Dinan, J.F Cryan Ghrelin signalling and obesity: at the interface of stress, mood and food reward. Pharmacol Therapeut 2012;135(3):316 – 326. [97] A.C. Incollingo Rodriguez, E.S. Epel, M.L. White, E.C. Standen, J.R. Seckl, A.J Tomiyama Hypothalamic-pituitary-adrenal axis dysregulation and cortisol activity in obesity: a systematic review. Psychoneuroendocrinology 2015;62:301 – 318. [98] T. Kuo, A. McQueen, T.C. Chen, J.C Wang Regulation of glucose homeostasis by glucocorticoids. Adv Exp Med Biol 2015;872:99 – 126. [99] A. Bali, A.S. Jaggi An integrative review on role and mechanisms of ghrelin in stress, anxiety and depression. Curr Drug Targets 2016;17(5):495 – 507. [100] A. Everard, H. Plovier, M. Rastelli, M. Van Hul, A. de Wouters d ’ Oplinter, L. Geurts, et al. Intestinal epithelial N-acylphosphatidylethanolamine phospholipase D links dietary fat to metabolic adaptations in obesity and steatosis. Nat Commun 2019;10(1):457. [101] C. Depommier, A. Everard, C. Druart, H. Plovier, M. Van Hul, S. Vieira-Silva, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med 2019;25(7):1096 – 1103.

Powered by